X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (78) 78
humans (67) 67
ophthalmology (67) 67
voriconazole (53) 53
endophthalmitis (46) 46
intravitreal injections (45) 45
endophthalmitis - microbiology (43) 43
endophthalmitis - drug therapy (41) 41
eye infections, fungal - drug therapy (39) 39
eye infections, fungal - microbiology (38) 38
male (37) 37
vitrectomy (31) 31
middle aged (30) 30
antifungal agents - therapeutic use (29) 29
antifungal agents - administration & dosage (27) 27
animals (26) 26
intravitreal injection (26) 26
eye infections, fungal - diagnosis (25) 25
female (25) 25
intravitreal voriconazole (25) 25
aged (23) 23
endophthalmitis - diagnosis (23) 23
fungal endophthalmitis (21) 21
pharmacology & pharmacy (21) 21
pyrimidines - therapeutic use (17) 17
visual acuity (17) 17
triazoles - therapeutic use (16) 16
eye diseases (15) 15
surgery (15) 15
treatment outcome (15) 15
amphotericin-b (14) 14
rabbits (14) 14
adult (13) 13
amphotericin b (13) 13
infections (13) 13
retrospective studies (13) 13
care and treatment (12) 12
cataract (12) 12
genetic structures (12) 12
health aspects (12) 12
intravitreal (12) 12
pharmacokinetics (12) 12
antibiotics (11) 11
cataract-surgery (11) 11
endogenous endophthalmitis (11) 11
eye (11) 11
keratitis (11) 11
microbiology (11) 11
antifungal agents (10) 10
endophthalmitis - therapy (10) 10
infection (10) 10
triazoles - administration & dosage (10) 10
aged, 80 and over (9) 9
endogenous fungal endophthalmitis (9) 9
endophthalmitis - pathology (9) 9
eye infections, fungal - therapy (9) 9
medicine & public health (9) 9
mycoses - microbiology (9) 9
pyrimidines - administration & dosage (9) 9
sense organs (9) 9
vitreous body - microbiology (9) 9
bevacizumab (8) 8
candidiasis - drug therapy (8) 8
caspofungin (8) 8
diagnosis (8) 8
drug delivery systems (8) 8
mycoses (8) 8
risk factors (8) 8
toxicity (8) 8
voriconazole - administration & dosage (8) 8
amphotericin b - therapeutic use (7) 7
analysis (7) 7
aspergillosis - drug therapy (7) 7
aspergillus endophthalmitis (7) 7
combined modality therapy (7) 7
drug therapy (7) 7
drug therapy, combination (7) 7
drugs (7) 7
eye infections, fungal - pathology (7) 7
fluconazole (7) 7
injections (7) 7
mycology (7) 7
patients (7) 7
pharmacy (7) 7
review (7) 7
amphotericin b - administration & dosage (6) 6
anti-bacterial agents - therapeutic use (6) 6
antifungal agents - pharmacokinetics (6) 6
aspergillus (6) 6
candidiasis - diagnosis (6) 6
endophthalmitis - epidemiology (6) 6
eye infections, fungal - epidemiology (6) 6
eye surgery (6) 6
fungi (6) 6
fungi - isolation & purification (6) 6
infectious diseases (6) 6
lipopeptides (6) 6
management (6) 6
mycoses - drug therapy (6) 6
postoperative complications (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2009, Volume 53, Issue 5, pp. 2156 - 2157
Journal Article
Ocular Immunology and Inflammation, ISSN 0927-3948, 2019, pp. 1 - 8
Candida endophthalmitis represents a therapeutic challenge, considering the inability of many antifungals to achieve adequate concentrations in the vitreous.... 
voriconazole | clinical outcome | retrospective review | Candida | safety | endophthalmitis | intravitreal injection
Journal Article
Toxicology, ISSN 0300-483X, 2009, Volume 258, Issue 2, pp. 84 - 93
Abstract Fungal keratitis is a sight-threatening infection of the cornea. It sometimes leads to loss of the eye. Despite an expanding range of fungal... 
Emergency | Fungal keratitis | Keratomycosis | Intracameral drug application | Amphotericin B | Voriconazole | AMPHOTERICIN-B INJECTION | ASPERGILLUS ENDOPHTHALMITIS | INTRAOCULAR-PRESSURE | CATARACT-SURGERY | CORNEAL ULCERATION | ETIOLOGIC DIAGNOSIS | INTRAVITREAL VORICONAZOLE | RURAL BANGLADESH | PHARMACOLOGY & PHARMACY | TOXICOLOGY | FUSARIUM KERATITIS | Triazoles - adverse effects | Antifungal Agents - adverse effects | Pigment Epithelium of Eye - drug effects | Triazoles - chemistry | Cell Count | Humans | Trabecular Meshwork - drug effects | Culture Media, Serum-Free | Antifungal Agents - chemistry | Pyrimidines - chemistry | Dose-Response Relationship, Drug | Pyrimidines - toxicity | Tetrazolium Salts - metabolism | Triazoles - toxicity | Time Factors | Eye - drug effects | Molecular Structure | Drug Evaluation, Preclinical | Antifungal Agents - toxicity | Organ Culture Techniques | Trabecular Meshwork - cytology | Cell Survival - drug effects | Endothelium, Corneal - cytology | Cells, Cultured | Hydrogen Peroxide - pharmacology | Eye - cytology | Endothelium, Corneal - drug effects | Tumor Necrosis Factor-alpha - pharmacology | Interleukin-6 - pharmacology | Lipopolysaccharides - pharmacology | Pyrimidines - adverse effects | Cell Proliferation - drug effects | Pigment Epithelium of Eye - cytology | Formazans - metabolism | Cell research | Safety and security measures | Hydrogen peroxide | Triazoles | Analysis | Antiparasitic agents | Endothelium | Index Medicus
Journal Article
Journal of Chemotherapy, ISSN 1120-009X, 04/2015, Volume 27, Issue 2, pp. 111 - 113
Purpose: Systemic voriconazole treatment was reported to cause photosensitivity and related cutaneous malignancies. The aim of this report is to demonstrate a... 
Confocal microscopy | Cornea | Dysplasia | Penetrating keratoplasty | Candida | Voriconazole | INFECTIOUS DISEASES | ONCOLOGY | PHARMACOLOGY & PHARMACY | Neoplasms, Squamous Cell - diagnosis | Administration, Ophthalmic | Antifungal Agents - adverse effects | Corneal Opacity - chemically induced | Intravitreal Injections | Humans | Male | Candidiasis - microbiology | Antifungal Agents - therapeutic use | Neoplasms, Squamous Cell - chemically induced | Voriconazole - administration & dosage | Cornea - drug effects | Precancerous Conditions - diagnosis | Candidiasis - drug therapy | Corneal Opacity - diagnosis | Corneal Diseases - chemically induced | Precancerous Conditions - pathology | Cornea - pathology | Corneal Diseases - pathology | Neoplasms, Squamous Cell - pathology | Endophthalmitis - drug therapy | Diagnosis, Differential | Voriconazole - adverse effects | Ophthalmic Solutions - administration & dosage | Ophthalmic Solutions - therapeutic use | Eye Neoplasms - pathology | Ophthalmic Solutions - adverse effects | Voriconazole - therapeutic use | Treatment Outcome | Eye Neoplasms - chemically induced | Candida - isolation & purification | Corneal Diseases - diagnosis | Eye Neoplasms - diagnosis | Microscopy, Confocal | Corneal Opacity - pathology | Endophthalmitis - microbiology | Aged | Candida - drug effects | Precancerous Conditions - chemically induced | Antifungal Agents - administration & dosage | Injections, Intraocular | Index Medicus
Journal Article
Journal Article
Journal Article
Clinical Ophthalmology, ISSN 1177-5467, 04/2015, Volume 9, pp. 649 - 655
To report outcomes of exogenous fungal endophthalmitis treated with combination of intravitreal antifungal agents. Retrospective, non-randomized,... 
Endophthalmitis | Aspergillus | Intravitreal | Amphotericin B | Fungal | Voriconazole | Drug therapy | Patient outcomes | Drugs | Fungi | Cataracts | Ultrasonic imaging | Microbiology | Microscopy | Photographs | Ophthalmology | Eye surgery | Health risk assessment | Eyes | Medical services | Strategy | Visual acuity | Globes | Visual
Journal Article